Your browser doesn't support javascript.
loading
Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson Syndrome.
Xie, Tao; Wills, Anne-Marie; Liao, Chuanhong; Dale, Marian L; Ramsden, David B; Padmanaban, Mahesh; Abou Chaar, Widad; Pantelyat, Alexander; Golbe, Lawrence I.
Afiliação
  • Xie T; Department of Neurology, University of Chicago Medicine, Chicago, Illinois, USA.
  • Wills AM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Liao C; Biostatistics Laboratory, Department of Public Health Sciences, University of Chicago Medicine, Chicago, Illinois, USA.
  • Dale ML; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
  • Ramsden DB; Institute of Metabolism and Systems Research of Medical School, University of Birmingham, Birmingham, United Kingdom.
  • Padmanaban M; Department of Neurology, University of Chicago Medicine, Chicago, Illinois, USA.
  • Abou Chaar W; Department of Neurology, University of Chicago Medicine, Chicago, Illinois, USA.
  • Pantelyat A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Golbe LI; Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Mov Disord ; 38(2): 304-312, 2023 02.
Article em En | MEDLINE | ID: mdl-36573662
ABSTRACT

BACKGROUND:

Rapid development of downgaze palsy, the most specific symptom of progressive supranuclear palsy (PSP), has been associated with shorter survival in small studies.

OBJECTIVE:

We hypothesized that the progression rate of downgaze palsy and other disease features could predict survival if assessed soon after the onset of downgaze palsy in a large data set.

METHODS:

We used a longitudinal database of 414 patients with probable PSP-Richardson syndrome from 1994 to 2020. The data set comprised demographics and, for each visit, 28 PSP Rating Scale (PSPRS) items and PSP stage scores. We calculated the rate of progression of each PSPRS item as its item score when the downgaze item first reached 1 or more (on a 0-4 scale) divided by disease duration at that point. Multivariate Cox regression was applied to identify variables independently associated with survival. We also explored the progression pattern of total PSPRS and downgaze palsy scores with disease course.

RESULTS:

Independently associated with shorter survival were older onset age and faster progression of downgaze palsy, dysphagia for liquids, difficulty in returning to seat, and PSP stage. Patients with survival duration within 1 year of the median survival (6.58 years) showed approximately linear progression of the PSPRS score and downgaze palsy score during years 2 through 6 of the disease course.

CONCLUSIONS:

Older onset age and faster progression of downgaze palsy and several axial features are associated with shorter survival. The disease typically progresses in approximately linear fashion during years 2 through 6. These results may aid study design and patient counseling. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva / Transtornos de Deglutição / Transtornos dos Movimentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Supranuclear Progressiva / Transtornos de Deglutição / Transtornos dos Movimentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos